Compass Therapeutics to Participate in the Leerink Partners Global Biopharma ConferenceBOSTON, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
Globe Newswire•5 months ago